Table 3.
Model | Strain | Treatment | Symptom | Ref. |
---|---|---|---|---|
Picryl chloride | WBB6F-KitW/W-v | None | Attenuated | [61] |
WCB6F-SI/SId | ||||
Oxazolone | WBB6F-KitW/W-v | No significance | [67] | |
Picryl chloride | KitWf/Wf | |||
DNFB | MCPT-5-Cre DTA | Attenuated | [12] | |
FITC | ||||
Urushiol | B6-KitW-sh/W-sh | Exacerbated | [14,28,68] | |
DNFB | WBB6F-KitW/W-v | |||
Oxazolone | B6-KitW-sh/W-sh | |||
DNFB | KitW-sh/W-sh | |||
Mcpt5-Cre DTA | ||||
Cpa3-Cre Mcl-1fl/fl | ||||
Mcpt5-Cre Il10fl/fl | ||||
chronic low-dose UVB | WBB6F-KitW/W-v | |||
DNFB | B6-KitW-sh/W-sh | BMMC reconstitution | Attenuated | [14,28,68] |
Oxazolone | ||||
chronic low-dose UVB | WBB6F-KitW/W-v | |||
Oxazolone | C3H/HeN | pre-IgE-XL | Attenuated | [62] |
WCB6F-SI/SId | pre-UVB irradiation | Loss of UVB-induced imunosuppression | [27,62] | |
DNP-KLH | B6-KitW-sh/W-sh | |||
BMMC reconstitution and pre-UVB irradiation |
Abbreviations: B6; C57BL/6, IgE-XL; IgE crosslink.